Owing to the complexity of the original TME, a murine CT26 colon cancer model was established in immunocompetent BALB/c mice to further assess the effect of IL-33 treatment on 5-FU chemotherapy (Figure 8E). Here, IL33 is linked to malignant colon neoplasm.